Korean J Hepatol.  2006 Mar;12(1):107-111.

A Case of Infiltrative Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis Successfully Treated by Transarterial Chemoembolization

Affiliations
  • 1Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. yoonjh@snu.ac.kr
  • 2Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.

Abstract

A 63-year-old HBsAg-positive male patient was admitted for the evaluation of a liver mass that was detected on ultrasonography. Spiral computed tomography (CT) revealed infiltrative hepatocellular carcinoma (HCC) in the right hepatic lobe with main portal vein tumor thrombosis. His liver function was Child-Pugh class A and the serum alpha fetoprotein level was 7,400 ng/mL. Transarterial chemoembolization (TACE) via the right hepatic artery was performed. Following 3 sessions of TACE every 2 months, spiral CT revealed no evidence of viable tumor. The thrombi within the main portal vein disappeared with performing localized hepatic infarction at the site of the previous tumor. He is still alive 15 months after the third TACE without evidence of recurred tumor and his liver function remains well preserved. This case suggests that TACE might be effective and safe even in the patients with infiltrative HCC with main portal vein tumor thrombosis, if the extent of the tumor is limited and the liver function and portal flow via the collaterals are preserved.

Keyword

Hepatocellular carcinoma; Venous thrombosis; Transarterial chemoembolization; Therapeutics

MeSH Terms

Venous Thrombosis/*complications
Portal Vein
Middle Aged
Male
Liver Neoplasms/complications/radiography/*therapy
Humans
*Chemoembolization, Therapeutic
Carcinoma, Hepatocellular/complications/radiography/*therapy
Full Text Links
  • KJHEP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr